Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials
摘要：
Throughout Europe and the U.S., over 60% of the total incidence of cancer occurs in the elderly (≥65 years) population, a patient group that requires particular consideration when making treatment decisions due to a number of factors. Despite this, elderly patients are generally under-represented in clinical trials such that study data should be interpreted with caution because results in younger cancer patients may not always extrapolate to the typical elderly cancer patient.
展开
DOI：
10.1634/theoncologist.10-3-198
被引量：
年份：
2005
Wiley
academic.oup.com
Wiley
doi.org
万方医学
查看更多
Europe PMC
NCBI
NCBI
Oxford Univ Press
The Lancet
ResearchGate
onAcademic
pubfacts.com
www.socolar.com
jacionline.org
theoncologist.alphamedpress.org
theoncologist.alphamedpress.org
(全网免费下载)
jco.ascopubs.org
mysciencework.com
mendeley.com
haematologica.org
lungcancerjournal.info
pubget.com
repository.library.georgetown.edu
cebp.aacrjournals.org
theoncologist.alphamedpress.org
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
